In addition, Peptide 17 is able to repress N6-methyladenosine (m6A)’s methyltransferase 3 (METTL3) expression, leading to a decrease in YAP1 mRNA expression and of the consequent tumour-promoting effects in GC [139]. The gene discussed is YAP1; the disease is neoplasm.